natgillin/translations-raw huggingface dataset:
Leflunomide is indicated for the treatment of adult patients with: active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD). active psoriatic arthrit is.
Leflunomid je indiciran u liječenju odraslih bolesnika s: aktivnim reumatoidnim artritisom kao antireumatik koji modificira tijek bolesti (DMARD od engl. disease-modifying antirheumatic drug), aktivnim psorijatičnim artritisom.
Leflunomide is indicated for the treatment of adult patients with: active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD). active psoriatic arthritis.
Leflunomid je indiciran u liječenju odraslih bolesnika s: aktivnim reumatoidnim artritisom kao antireumatik koji modificira tijek bolesti (DMARD od engl. disease-modifying antirheumatic drug), aktivnim psorijatičnim artritisom.
Leflunomide is metabolised to one primary (A771726) and many minormetabolites including TFMA (4-trifluoromethylaniline).
Leflunomid se metabolizira u jedan glavni (A771726) i više manjih metabolita, uključujući (4 trifluorometilanilin).
Leflunomide is rapidly converted to theactivemetabolite, A771726, by first-pass metabolism (ring opening) in gut wall and liver.
Leflunomid se brzo metabolizira u aktivni metabolit, A771726, prvim prolaskom kroz stijenku crijeva i jetru (otvaranje prstena).
Leflunomide medac 10 mg film-coated tablets
Leflunomid medac 10 mg filmom obložene tablete
Leflunomide medac 10 mg film-coated tablets Leflunomide medac 15 mg film-coated tablets Leflunomide medac 20 mg film-coated tablets
Leflunomid medac 10 mg filmom obložene tablete Leflunomid medac 15 mg filmom obložene tablete Leflunomid medac 20 mg filmom obložene tablete
Leflunomide medac 10 mg film-coated tablets: Pack sizes of 30, 60, 90 or 100 film-coated tablets per bottle are available.
Leflunomid medac 10 mg filmom obložene tablete: Dostupne su veličine pakovanja od 30, 60, 90 ili 100 filmom obloženih tableta u boci.
Leflunomide medac 10 mg Leflunomide medac 15 mg Leflunomide medac 20 mg
Leflunomid medac 10 mg Leflunomid medac 15 mg Leflunomid medac 20 mg
Leflunomide medac 15 mg film-coated tablets
Leflunomid medac 15 mg filmom obložene tablete
Leflunomide medac 15 mg film-coated tablets are white to almost white and round with a diameter of about 7 mm.
Leflunomid medac 15 mg filmom obložene tablete su bijele do gotovo bijele, okrugle, filmom obložene tablete, promjera otprilike 7 mm.
Leflunomide medac 20 mg film-coated tablets
Leflunomid medac 20 mg filmom obložene tablete
Leflunomide medac 20 mg film-coated tablets: Pack sizes of 15, 30, 60, 90 or 100 film-coated tablets per bottle are available.
Leflunomid medac 20 mg filmom obložene tablete: Dostupne su veličine pakovanja od 15, 30, 60, 90 ili 100 filmom obloženih tableta u boci.
Leflunomide medac contains soya lecithin.
Leflunomid medac sadrži sojin lecitin
Leflunomide medac is a ‘generic medicine’.
Leflunomide medac je „generički lijek”.
Leflunomide medac is notrecommended foruse in children and adolescents below 18 years of age .
Leflunomid medac se ne preporučuje za primjenu u djece i adolescenata mlađih od 18 godina.
Leflunomide medac is used to treat adult patients with active rheumatoid arthritis or with active psoriatic arthrit is.
Leflunomid medac se primjenjuje za liječenje odraslih bolesnika s aktivnim oblikom reumatoidnog artritisa ili aktivnim oblikom psorijatičnog artritisa.
Leflunomide medac may be taken with or without food.
Leflunomid medac može se uzeti s hranom ili bez nje.
Leflunomide medac treatment usually starts with a ‘loading dose’ of 100 mg once a day for three days, followed by a maintenance dose.
Liječenje lijekom Leflunomide medac obično započinje „udarnom dozom” od 100 mg na dan jednom dnevno tijekom tri dana, nakon čega slijedi doza održavanja.
Leflunomide medac with food, drink and alcohol
Leflunomid medac s hranom, pićem i alkoholom
Leflunomide ratiopharm 10 mg film-coated tablets
Leflunomid ratiopharm 10 mg filmom obložene tablete
Leflunomide ratiopharm 10 mg film-coated tablets are white to almost white and round with a diameter of about 6 mm.
Leflunomid ratiopharm 10 mg filmom obložene tablete su bijele do gotovo bijele i okrugle, promjera oko 6 mm.
Leflunomide ratiopharm 10 mg tablets Leflunomide
Leflunomid ratiopharm 10 mg tablete leflunomid
Leflunomide ratiopharm 20 mg film-coated tablets
Leflunomid ratiopharm 20 mg filmom obložene tablete
Leflunomide ratiopharm 20 mg film-coated tablets are white to almost white and round with a diameter of about 8 mm and a break-mark on one side of the tablet.
Leflunomid ratiopharm 20 mg filmom obložene tablete su bijele do gotovo bijele i okrugle, promjera 8 mm, s razdjelnom crtom na jednoj strani tablete.
Leflunomide ratiopharm 20 mg tablets Leflunomide
Leflunomid ratiopharm 20 mg tablete leflunomid
Leflunomide ratiopharm contains lactose
Leflunomid ratiopharm sadrži laktozu.
Leflunomide ratiopharm is a ‘generic medicine’.
Leflunomide ratiopharm je "generički lijek".
Leflunomide ratiopharm is contraindicated in pregnancy (see section 4.3).
Leflunomid ratiopharm je kontraindiciran u trudnoći (vidjeti dio 4.3).
Leflunomide ratiopharm may be taken with or without food.
Leflunomid ratiopharm se može uzeti s hranom ili bez nje.
Leflunomide ratiopharm treatment starts with a ‘loading dose’ of 100 mg once a day for three days, followed by a maintenance dose.
Liječenje lijekom Leflunomide ratiopharm obično započinje „udarnom dozom” od 100 mg na dan jednom dnevno tijekom tri dana, nakon čega slijedi doza održavanja.
Leflunomide ratiopharm with food, drink and alcohol
Leflunomid ratiopharm s hranom, pićem i alkoholom
Leflunomide Teva
Leflunomid Teva
Leflunomide Teva 10 mg film-coated tablets
Leflunomid Teva10 mg filmom obložene tablete
Leflunomide Teva 10 mg film-coated tablets are white, round film-coated tablets, engraved with “10” on one side and “L” on the other.
Leflunomid Teva 10 mg filmom obložene tablete su bijele, okrugle, filmom obložene tablete, s utisnutom oznakom „10“ na jednoj strani i „L“ na drugoj.
Leflunomide Teva 10 mg film-coated tablets leflunomide
Leflunomid Teva 10 mg filmom obložene tablete leflunomid
Leflunomide Teva 10 mg tablets leflunomide
Leflunomid Teva 10 mg tablete leflunomid
Leflunomide Teva 20 mg film-coated tablets are dark beige, triangle shaped, film-coated tablets, engraved with ”20” on one side and “L” on the other.
Leflunomid Teva 20 mg filmom obložene tablete su tamno bež, filmom obložene tablete, trokutastog oblika, s utisnutom oznakom „20“ na jednoj strani i „L“ na drugoj.
Leflunomide Teva 20 mg film-coated tablets leflunomide
Leflunomid Teva 20 mg filmom obložene tablete leflunomid
Leflunomide Teva 20 mg tablets leflunomide
Leflunomid Teva 20 mg tablete leflunomid
Leflunomide Teva belongs to a group of medicines called anti-rheumatic medicines.
Leflunomid Teva pripada skupini antireumatskih lijekova.
Leflunomide Teva can occasionally cause some problems with your blood, liver, lungs, or nerves in your arms or legs.
Leflunomid Teva može povremeno uzrokovati probleme s krvi, jetrom, plućima ili živcima u rukama ili nogama.
Leflunomide Teva contains lactose.
Leflunomid Teva sadrži laktozu.
Leflunomide Teva is used to treat adult patients with active rheumatoid arthritis.
Leflunomid Teva primjenjuje se za liječenje odraslih bolesnika s aktivnim oblikom reumatoidnog artritisa.
Leflunomide Teva stored in blisters are available in pack sizes of 28, 30 and 100 film-coated tablets.
Leflunomid Teva u blisterima je dostupan u veličinama pakovanja od 28, 30 i 100 filmom obloženih tableta.
Leflunomide Teva stored in blisters are available in pack sizes of 28, 30 and 100 film-coated tablets.
Leflunomid Teva u bočicama je dostupan u veličinama pakovanja od 28, 30 i 100 filmom obloženih tableta.
Leflunomide Teva stored in bottles are available in pack sizes of 30 and 100 film-coated tablets.
Leflunomid Teva u bočicama je dostupan u veličinama pakovanja od 30 i 100 filmom obloženih tableta.
Leflunomide was administered as a single oral 100 mg dose to 3 haemodialysis patients and 3 patients on continuous peritoneal dialysis (CAPD).
Jednu peroralnu dozu od 100 mg leflunomida primila su 3 hemodijalizirana bolesnika i 3 bolesnika na kontinuiranoj peritonealnoj dijalizi (CAPD).
Leflunomide Winthrop 10 mg film-coated tablets
Leflunomide Winthrop 10 mg filmom obložene tablete
Leflunomide Winthrop 10 mg film-coated tablets are white to almost white and round.
Leflunomide Winthrop 10 mg filmom obložene tablete su bijele do gotovo bijele i okrugle.
Leflunomide Winthrop 10 mg film-coated tablets leflunomide
Leflunomide Winthrop 10 mg filmom obložene tablete leflunomid
Leflunomide Winthrop 100 mg film-coated tablets
Leflunomide Winthrop 100 mg filmom obložene tablete
Leflunomide Winthrop 100 mg film-coated tablets are white to almost white and round.
Leflunomide Winthrop 100 mg filmom obložene tablete su bijele do gotovo bijele i okrugle.
Leflunomide Winthrop 100 mg film-coated tablets leflunomide
Leflunomide Winthrop 100 mg filmom obložene tablete leflunomid
Leflunomide Winthrop 20 mg film-coated tablets
Leflunomide Winthrop 20 mg filmom obložene tablete
Leflunomide Winthrop 20 mg film-coated tablets are yellowish to ochre and triangular.
Leflunomide Winthrop 20 mg filmom obložene tablete su žućkaste do oker boje i trokutastog oblika.
Leflunomide Winthrop 20 mg film-coated tablets leflunomide
Leflunomide Winthrop 20 mg filmom obložene tablete leflunomid
Leflunomide Winthrop belongs to a group of medicines called anti-rheumatic medicines.
Leflunomide Winthrop pripada skupini lijekova koji se zovu antireumatski lijekovi.
Leflunomide Winthrop can make you feel dizzy which may impair your ability to concentrate and react.
Leflunomide Winthrop može izazvati omaglicu, što može smanjiti sposobnost koncentracije i reagiranja.
Leflunomide Winthrop can occasionally cause some problems with your blood, liver, lungs or nerves in your arms or legs.
Leflunomide Winthrop može povremeno uzrokovati probleme s krvi, jetrom, plućima ili živcima u rukama ili nogama.
Leflunomide Winthrop can occasionally cause some problems with your blood, liver, lungs, or nerves in your arms or legs.
Leflunomide Winthrop može povremeno uzrokovati probleme s krvi, jetrom, plućima ili živcima u rukama ili nogama.
Leflunomide Winthrop contains lactose
Leflunomide Winthrop sadrži laktozu
Leflunomide Winthrop contains lactose.
Leflunomide Winthrop sadrži laktozu.
Leflunomide Winthrop is a medicine that contains the active substance leflunomide.
Leflunomide Winthrop je lijek koji sadrži djelatnu tvar leflunomid.
Leflunomide Winthrop is contraindicated in patients with severe hypoproteinaemia or impairment of liver function (see section 4.3).
Leflunomide Winthrop je kontraindiciran u bolesnika s teškom hipoproteinemijom ili oštećenom jetrenom funkcijom (vidjeti dio 4.3).
Leflunomide Winthrop is contraindicated in pregnancy (see section 4.3).
Leflunomide Winthrop je kontraindiciran u trudnoći (vidjeti dio 4.3).
Leflunomide Winthrop is contraindicated in pregnancy(see section 4.3).
Leflunomide Winthrop je kontraindiciran u trudnoći (vidjeti dio 4.3).
Leflunomide Winthrop is not recommended for use in children and adolescents below 18 years of age.
Leflunomide Winthrop se ne preporučuje za primjenu u djece i adolescenata mlađih od 18 godina.
Leflunomide Winthrop is not recommended for use in patients below 18 years since efficacy and safety in juvenile rheumatoid arthritis (JRA) have not been established (see sections 5.1 and 5.2).
Leflunomide Winthrop se ne preporučuje bolesnicima mlađima od 18 godina jer djelotvornost i sigurnost primjene kod juvenilnog reumatoidnog artritisa (JRA) nisu ustanovljene (vidjeti dijelove 5.1 i 5.2).
Leflunomide Winthrop is not recommended for use in patients below 18 years since efficacy and safety in juvenile rheumatoid arthritis (JRA) have not been established (see sections 5.1 and 5.2).
Leflunomide Winthrop se ne preporučuje bolesnicima mlađima od 18 godina, jer djelotvornost i sigurnost primjene kod juvenilnog reumatoidnog artritisa (JRA) nisu ustanovljene (vidjeti dio 5.1 i 5.2).
Leflunomide Winthrop is used to treat adult patients with active rheumatoid arthritis or with active psoriatic arthritis.
Leflunomide Winthrop se primjenjuje za liječenje odraslih bolesnika s aktivnim oblikom reumatoidnog artritisa ili aktivnim oblikom psorijatičnog artritisa.
Leflunomide Winthrop is used to treat adults with active rheumatoid arthritis (an immune system disease causing inflammation of the joints) or active psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints).
Leflunomide Winthrop se koristi za liječenje odraslih osoba s aktivnim reumatoidnim artritisom (bolešću imunosnog sustava koja uzrokuje upalu zglobova) ili aktivnim psorijatičnim artritisom (bolešću koja uzrokuje crvenilo, mjestimično prhutanje kože i upale zglobova).
Leflunomide Winthrop leflunomide
Leflunomide Winthrop leflunomid
Leflunomide Winthrop may be taken with or without food.
Leflunomide Winthrop se može uzimati s hranom ili bez nje.
Leflunomide Winthrop must not be used in patients with:
Leflunomide Winthrop se ne smije koristiti u bolesnika s:
Leflunomide Winthrop must not be used in people who may be hypersensitive (allergic) to leflunomide, to teriflunomide (a breakdown product of leflunomide) or to any of the other ingredients.
Leflunomide Winthrop se ne smije primjenjivati u osoba koje su preosjetljive (alergične) na leflunomid, na teriflunomid (ishodišni spoj za leflunomid) ili na bilo koju drugu pomoćnu tvar.
Leflunomide Winthrop must not be used in pregnant women, in women who can become pregnant and who are not using reliable contraception or during breast-feeding.
Leflunomide Winthrop se ne smije koristiti u trudnica, žena reproduktivne dobi te žena koje ne koriste pouzdanu kontracepciju, niti tijekom dojenja.
Leflunomide Winthrop tablets are for oral use.
Leflunomide Winthrop tablete namijenjene su za peroralnu primjenu.
Leflunomide Winthrop treatment should be started and supervised by a specialist who has experience in the treatment of rheumatoid arthritis and psoriatic arthritis.
Liječenje lijekom Leflunomide Winthrop mora započeti i nadzirati liječnik specijalist s iskustvom u liječenju reumatoidnog i psorijatičnog artritisa.
Leflunomide Winthrop treatment usually starts with a ‘loading dose’ of 100 mg once a day for three days, followed by a maintenance dose.
Terapija lijekom Leflunomide Winthrop najčešće se započinje „dozom punjenja“ od 100 mg jednom na dan tijekom tri dana, nakon čega slijedi doza održavanja.
Leflunomide Winthrop was not as effective as methotrexate in the extension study.
Leflunomide Winthrop nije bio podjednako djelotvoran kao metotreksat u produljenom ispitivanju.
Leflunomide Winthrop with food, drink and alcohol
Leflunomide Winthrop s hranom, pićem i alkoholom
leflunomide, methotrexate and other medicines that affect the immune system (often called immunosuppressants or immunomodulators)
leflunomid, metotreksat i druge lijekove koji utječu na imunološki sustav (često se nazivaju imunosupresivima ili imunomodulatorima)
left lower back or right lower back
lijeva ili desna strana donjeg dijela leđa
Left over Nplate in the vial must NEVER be re-used for another injection.
Preostali Nplate u bočici NIKAD se ne smije ponovno uporabiti za drugu injekciju.
Left to right panels show sagittal, coronal, and transverse PET image slices.
Stupci slijeva nadesno prikazuju PET snimke sagitalnih, koronalnih i transverzalnih presjeka.
Left untreated, larger deposits called tophi may form in and around joints.
Ako se ne liječi, u zglobovima i okolnom vezivu se mogu stvarati veće nakupine kristala urata, koji se zovu tofi.
left upper arm or right upper arm
lijeva nadlaktica ili desna nadlaktica
left upper back or right upper back
lijeva ili desna strana gornjeg dijela leđa
left upper back or right upper back left lower back or right lower back
lijeva ili desna strana gornjeg dijela leđa lijeva ili desna strana donjeg dijela leđa
left upper chest or right upper chest (avoid breast)
gornji dio lijevog ili desnog dijela prsnog koša (izbjegavati dojke)
Left ventricular dysfunction † (including congestive heart failure)**
disfunkcija lijeve klijetke † (uključujući kongestivno zatajenje srca)
Left ventricular dysfunction, cardiac disorder, cardiac failure congestive, bundle branch block, tachycardia
Poremećaj rada lijeve klijetke, srčani poremećaj, kongestivno zatajenje srca, blok grane srčanog snopa, tahikardija
Left ventricular ejection fraction (LVEF) reduction/Left ventricular dysfunction
Smanjenje ejekcijske frakcije lijeve klijetke/disfunkcija lijeve klijetke
Leg cramps
grčevi u nogama
Leg cramps, bone pain, musculoskeletal pain
grčevi u nogama, bolovi u kostima, mišićno- koštana bol
Leg cramps.
grčevi u nogama.
Leg or arm pain or swelling (which could be a symptom of blood clots in the deep veins of the leg or arm), chest pain or shortness of breath (which may be a symptom of blood clots in the lungs)
Bol ili oticanje nogu ili ruku (što može biti simptom krvnih ugrušaka u dubokim venama nogu ili ruku), bolovi u prsnom košu ili nedostatak zraka (što može biti simptom krvnih ugrušaka u plućima)
leg pain
bol u nogama
Leg pain (which could be a symptom of thrombosis), chest pain or shortness of breath (which may be a symptom of blood clots in the lungs, called pulmonary embolism)
bol u nogama (koji može biti simptom tromboze), bol u prsištu ili nedostatak zraka (što može biti simptom krvnih ugrušaka u plućima, zvanih plućna embolija)
leg pain or stomach pain
bol u nogama ili u trbuhu
Leg ulcers
vaskularni ulkusi nogu
leganto 1 mg/24 h
leganto1 mg/24 h
Leganto 1 mg/24 h transdermal patch
Leganto 1 mg/24 h transdermalni flaster
Leganto 1 mg/24 h transdermal patch rotigotine
Leganto 1 mg/24 h tansdermalni flaster rotigotin
Leganto 2 mg/24 h Leganto 4 mg/24 h Leganto 6 mg/24 h Leganto 8 mg/24 h Transdermal patch Rotigotine
Leganto 2 mg/24 h Leganto 4 mg/24 h Leganto 6 mg/24 h Leganto 8 mg/24 h Transdermalni flaster rotigotin
Leganto 2 mg/24 h transdermal patch
Leganto 2 mg/24 h transdermalni flaster
Leganto 2 mg/24 h transdermal patch rotigotine
Leganto 2 mg/24 h tansdermalni flaster rotigotin
Leganto 2 mg/24 h transdermal patch rotigotine
Leganto 2 mg/24 h transdermalni flaster rotigotin
Leganto 3 mg/24 h transdermal patch rotigotine
Leganto 3 mg/24 h tansdermalni flaster rotigotin
Leganto 4 mg/24 h instead of Leganto 2 mg/24 h) than your doctor told you to, contact your doctor or hospital for advice immediately, and follow their advice on changes of patches.
Leganto 4 mg/24 h umjesto Leganto 2 mg/24 h) od onog što Vam je liječnik rekao, javite svom liječniku ili bolnici za savjet te slijedite njihov savjet o tome kako odstraniti flastere.
Leganto 4 mg/24 h transdermal patch
Leganto 4 mg/24 h transdermalni flaster
Leganto 4 mg/24 h transdermal patch rotigotine
Leganto 4 mg/24 h tansdermalni flaster rotigotin
Leganto 6 mg/24 h transdermal patch
Leganto 6 mg/24 h transdermalni flaster
Leganto 6 mg/24 h transdermal patch
Leganto 6 mg/24h transdermalni flaster
Leganto 6 mg/24 h transdermal patch rotigotine
Leganto 6 mg/24 h tansdermalni flaster rotigotin
leganto 8 mg/24 h
leganto8 mg/24 h
Leganto 8 mg/24 h transdermal patch
Leganto 8 mg/24 h transdermalni flaster
Leganto 8 mg/24 h transdermal patch
Leganto 8 mg/24h transdermalni flaster
Leganto 8 mg/24 h transdermal patch rotigotine
Leganto 8 mg/24 h tansdermalni flaster rotigotin
Leganto can cause skin reactions, such as reddening and itching.
Leganto može uzrokovati reakcije na koži, kao što su crvenilo i svrbež.
Leganto contains sodium metabisulphite (E223)
Leganto sadrži natrijev metabisulfit (E223)
Leganto contains the active substance rotigotine.
Leganto sadrži djelatnu tvar rotigotin i dolazi u obliku flastera koji se primijenjuje na kožu.
Leganto contains the active substance rotigotine.
Leganto sadrži djelatnu tvar rotigotin i dolazi u obliku flastera koji se primijenjuju na kožu.
Leganto is a transdermal patch.
Leganto je transdermalni flaster.
Leganto is for transdermal use, a patch to be applied to the skin.
Leganto djeluje kroz kožu, a flaster se primijenjuje na kožu.
Leganto is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or ‘on-off’ fluctuations).
Leganto je indiciran za liječenje znakova i simptoma ranog stadija idiopatske Parkinsonove bolesti kao monoterapija (tj. bez levodope) ili u kombinaciji s levodopom, tj. tijekom trajanja bolesti i u njenoj završnoj fazi kada učinak levodope slabi ili postaje nestalan te se pojavljuju fluktuacije terapijskog učinka levodope (tzv. učinak kraja doze ili on-off fluktuacije).
Leganto is used to treat Restless Legs Syndrome (RLS) in adults that can be associated with discomfort in your legs or arms, urge to move around, sleep disturbance, tiredness or sleepiness during the day.
Leganto se primjenjuje u liječenju znakova i simptoma sindroma nemirnih nogu u odraslih koji mogu biti povezani sa nelagodom u Vašim nogama ili rukama, neodoljivom potrebom za kretanjem, poremećajem spavanja, umorom ili pospanošću tijekom dana.
Leganto is used to treat Restless Legs Syndrome (RLS) in adults that can be associated with discomfort in your legs or arms, urge to move around, sleep disturbance, tiredness or sleepiness during the day.
Leganto se primjenjuje u liječenju znakova i simptoma sindroma nemirnih nogu u odraslih koji može biti povezan sa nelagodom u vašim nogama ili rukama, neodoljivom potrebom za kretanjem, poremećajem spavanja, umorom ili pospanošću tijekom dana.
Leganto is used to treat the signs and symptoms of Parkinson’s disease in adults either alone or in combination with the medicine called levodopa.
Leganto se primjenjuje u liječenju znakova i simptoma Parkinsonove bolesti u odraslih kao jedini lijek ili u kombinaciji s lijekom koji se zove levodopa.
Leganto may cause abnormal thinking and behaviour.
Leganto može uzrokovati abnormalno porazmišljanje i ponašanje.
Leganto may cause abnormal thinking and behaviour.
Leganto može uzrokovati abnormalno razmišljanje i ponašanje.
Leganto may decrease blood pressure when you stand up; this effect may worsen by the medicine used to lower blood pressure. take sedating medicines (for example benzodiazepines, medicines used to treat mental conditions or depression) while you are using Leganto.
Leganto može sniziti krvni tlak prilikom ustajanja; taj učinak može pogoršati lijek za snižavanje krvnog tlaka uzimati sedative (npr. benzodiazepine, lijekove koji se koriste za liječenje duševnih bolesti ili depresije) dok primjenjujete Leganto.
Leganto may decrease blood pressure when you stand up; this effect may worsen by the medicine used to lower blood pressure. take sedating medicines (for example benzodiazepines, medicines used to treat mental conditions or depression) while you are using Leganto.
Leganto može sniziti krvni tlak prilikom ustajanja; taj učinak može pogoršati lijek za snižavanje krvnog tlaka. uzimati sedative (npr. benzodiazepine, lijekove koji se koriste za liječenje duševnih bolesti ili depresije) dok primjenjujete Leganto.
Leganto may decrease blood pressure when you stand up; this effect may worsen by the medicine used to lower blood pressure. take sedating medicines (for example benzodiazepines, medicines used to treat mental conditions or depression) while you are using Leganto.
Leganto može sniziti krvni tlak prilikom ustajanja; taj učinak može pogoršati lijek za snižavanje krvnog tlaka. uzimati sedative npr. benzodiazepine, lijekove koji se koriste za liječenje duševnih bolesti ili depresije) dok primjenjujete Leganto.
Leganto may make you feel very drowsy, and you may fall asleep very suddenly.
Tijekom primjene Leganta možete se osjećati jako pospano i čak posve iznenada zaspati.
Leganto should not be used by children because its safety and efficacy has not been established in children.
Leganto se ne smije primjenjivati u djece jer sigurnost i djelotvornost nisu utvrđeni u djece.
Leiomyoma (uterine fibroids) or endometriosis
leiomiom (fibroidi materice) ili endometriozu
Leiomyosarcoma
Leiomiosarkom